# Muscle Strength, Lipid Metabolism and Hepatic Steatosis Are Improved with Ursolic Acid Treatment in High-Fat Diet-Induced Obese Mice

**Authors:** Dongyang Kang, Li Cao

PMC · DOI: 10.3390/nu17193158 · 2025-10-05

## TL;DR

Ursolic acid improves obesity, muscle strength, and liver health in mice fed a high-fat diet.

## Contribution

Ursolic acid's effects on muscle function and NAFLD in obesity are newly demonstrated in a mouse model.

## Key findings

- Ursolic acid reduced body weight, fat, and liver weight in obese mice.
- Ursolic acid improved muscle strength and lipid profiles in treated mice.
- Ursolic acid reduced inflammation and improved liver histology in obese mice.

## Abstract

Background/Objectives: The prevalence of obesity globally has increased steadily in the past decades. Obesity, sarcopenic obesity (SO) and nonalcoholic fatty liver disease (NAFLD) commonly coexist. Ursolic acid (UA), a natural pentacyclic triterpenoid, has demonstrated potential anti-obesity properties. This study was designed to evaluate the anti-obesity efficacy of UA in a mouse model of high-fat diet (HFD)-induced obesity, with a particular focus on its impact on muscle function and NAFLD. Methods: Male C57BL/6J mice (6 weeks old) were randomly assigned to three groups (n = 20 per group): a control group (CON) fed a normal chow diet, a high-fat diet group (HFD), and a UA treatment group (UA). The HFD and UA groups received a high-fat diet for 10 weeks to induce obesity. Thereafter, mice in the UA group were administered UA orally once daily for 6 weeks. Results: In HFD-induced obese mice, UA administration significantly reduced body weight (BW), abdominal fat weight and liver weight; improved grip strength and muscle weight; and enhanced lipid profiles, including triglycerides, total cholesterol, low-density lipoprotein cholesterol and free fatty acid levels in serum. UA also improved histological changes in the liver and abdominal adipose tissues, regulated serum GH, IGF-1, T3, T4 and leptin levels and downregulated the inflammation-associated gene expression of TNF-α and IL-1β in abdominal adipose tissue. Conclusions: UA could enhance muscle strength, improve lipid metabolism and hepatic steatosis and might be considered a potential therapeutic agent for managing obesity and related metabolic diseases.

## Linked entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124], IL1B (interleukin 1 beta) [NCBI Gene 3553]
- **Chemicals:** ursolic acid (PubChem CID 64945), GH (PubChem CID 7023107), T3 (PubChem CID 5920), T4 (PubChem CID 5819), leptin (PubChem CID 157010069)
- **Diseases:** obesity (MONDO:0011122), nonalcoholic fatty liver disease (MONDO:0013209)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Gh (growth hormone) [NCBI Gene 14599] {aka Gh1, Ghb1}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}
- **Diseases:** metabolic diseases (MESH:D008659), NAFLD (MESH:D065626), inflammation (MESH:D007249), Obesity (MESH:D009765), Hepatic Steatosis (MESH:D005234)
- **Chemicals:** pentacyclic triterpenoid (MESH:D053978), T3 (MESH:D014284), cholesterol (MESH:D002784), T4 (MESH:D013974), free fatty acid (MESH:D005230), UA (MESH:C005466), Fat (MESH:D005223), triglycerides (MESH:D014280), Lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12525899/full.md

---
Source: https://tomesphere.com/paper/PMC12525899